MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
about
MiR-101 inhibits ovarian carcinogenesis by repressing the expression of brain-derived neurotrophic factor.The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines.Resting state intrinsic EEG impacts on go stimulus-response processes.Non-Viral Based miR Delivery and Recent Developments.The Network of Non-coding RNAs in Cancer Drug Resistance
P2860
MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MiR-101 and doxorubicin codeli ...... s of hepatocellular carcinoma.
@en
MiR-101 and doxorubicin codeli ...... s of hepatocellular carcinoma.
@nl
type
label
MiR-101 and doxorubicin codeli ...... s of hepatocellular carcinoma.
@en
MiR-101 and doxorubicin codeli ...... s of hepatocellular carcinoma.
@nl
prefLabel
MiR-101 and doxorubicin codeli ...... s of hepatocellular carcinoma.
@en
MiR-101 and doxorubicin codeli ...... s of hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
MiR-101 and doxorubicin codeli ...... s of hepatocellular carcinoma.
@en
P2093
Guang-Ya Xiang
Jia-Zhi Liao
Peng-Xuan Zhao
P2860
P304
P356
10.1002/CAM4.1016
P407
P50
P577
2017-01-30T00:00:00Z